公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma | Hu M.-H.; Chen L.-J.; Chen Y.-L.; Tsai M.-S.; Shiau C.-W.; Chao T.-I.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F. | Oncotarget | 17 | 15 | |
2014 | TD-19, an erlotinib derivative, induces epidermal growth factor receptor wild-type nonsmall-cell lung cancer apoptosis through CIP2A-mediated pathway | Chao T.-T.; Wang C.-Y.; Lai C.-C.; Chen Y.-L.; Tsai Y.-T.; Chen P.-T.; Lin H.-I.; Huang Y.-C.T.; Shiau C.-W.; CHONG-JEN YU ; Chen K.-F. | Journal of Pharmacology and Experimental Therapeutics | 28 | 28 | |
2021 | TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1 | Shih C.-T.; Shiau C.-W.; Chen Y.-L.; Chen L.-J.; Chao T.-I.; Wang C.-Y.; CHAO YUAN HUANG ; Hung M.-H.; Chen K.-F. | Cancer Letters | 13 | 10 | |
2015 | Treatment of liver cancer | Liu C.-Y.; Chen K.-F.; PEI-JER CHEN | Cold Spring Harbor Perspectives in Medicine | 244 | 200 |